NAT1 and colorectal carcinoma: Similarly, it was reported that NAT1 mRNA was reduced in colorectal carcinoma compared with normal tissues, while the methylation of the promoter region of NAT1 was higher in colorectal carcinoma than that in normal tissues (Shi et al., 2019).